Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH

Currency In CNY

AD

Valuation

Market Cap25.17B
Enterprise Value32.33B
P/E Ratio27.11
PEG Ratio0.3
Price/Sales Ratio2.67
Price/Book Ratio2.53
Enterprise/Revenue3.37
Enterprise/EBITDA22.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.11
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.1

Income Statement

Revenue8.54B
Revenue/Share6.44
Gross Profit4.7B
EBITDA1.59B
Net Income266.94M
Diluted EPS0.18

Balance Sheet

Total Cash2.26B
Total Cash/Share1.52
Total Debt8.94B
Total Debt/Equity0.89
Current Ratio1.2
Book Value Per Share6.94

Price History

52-Week Change-7.68
52-Week High19.14
52-Week Low13.73
Moving Average 50 Days16.41
Moving Average 200 Days16.13

Statistics

Average Volume29.17M
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.59
Payout Ratio0.35
Last Split Factor11:10
Last Split DateJune 08, 2020
AD